Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Recombinant human epidermal growth factor is versatile, effective, and safe for long-term skin and mucosal treatments.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Hirsutism causes significant psychological distress in women.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

PRP treatment may promote hair growth and improve hair density in women with AGA, but more research is needed.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

Finasteride can cause lasting sexual dysfunction, depression, and other side effects, needing more research for treatment.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Male pattern baldness may be caused by factors like poor blood circulation, scalp tension, stress, and hormonal imbalances, but the exact causes are still unclear.

Finasteride's solubility improves with native y-CDs, enhancing hair loss treatment and reducing side effects.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Inhibiting 5α-reductase increases progesterone levels in late pregnant mares.

Men with certain types of baldness at age 45 may have a higher risk of colon cancer and colorectal adenoma.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The document concludes that patients with skin of color need specialized dermatological care and education to manage unique skin conditions effectively.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Hair follicles and deer antlers regenerate similarly through stem cells and are influenced by hormones and growth factors.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

Finasteride-treated male rats' offspring had altered glucose metabolism, potentially increasing diabetes risk.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Metformin improved menstrual cycle regularity and signs of hyperandrogenism in adolescent girls with type 1 diabetes but did not improve blood sugar control.

The R343H mutation in the VDR gene causes vitamin D-resistant rickets with alopecia by impairing specific gene activity.